Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Summit Therapeu ADR (SMMT)

Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,819,414
  • Shares Outstanding, K 701,980
  • Annual Sales, $ 0 K
  • Annual Income, $ -614,930 K
  • 60-Month Beta -0.97
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 119.88
Trade SMMT with:

Options Overview Details

View History
  • Implied Volatility 87.49% ( +1.09%)
  • Historical Volatility 394.91%
  • IV Percentile 29%
  • IV Rank 13.73%
  • IV High 631.33% on 10/26/23
  • IV Low 0.93% on 07/25/23
  • Put/Call Vol Ratio 0.08
  • Today's Volume 506
  • Volume Avg (30-Day) 800
  • Put/Call OI Ratio 0.57
  • Today's Open Interest 41,082
  • Open Int (30-Day) 47,810

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year -0.02
  • Growth Rate Est. (year over year) -200.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.78 +28.02%
on 07/03/24
8.77 -1.03%
on 06/17/24
+1.14 (+15.12%)
since 06/11/24
3-Month
2.10 +313.33%
on 05/28/24
11.25 -22.84%
on 05/30/24
+4.65 (+115.38%)
since 04/11/24
52-Week
1.52 +471.05%
on 09/08/23
11.25 -22.84%
on 05/30/24
+6.61 (+319.32%)
since 07/11/23

Most Recent Stories

More News
3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street

These high-flying stocks could have more room to run if analysts are right.

MRK : 128.97 (+1.31%)
SMMT : 8.68 (+4.70%)
SMCI : 889.22 (-1.20%)
VKTX : 58.63 (+1.10%)
Summit Therapeutics Stock Jumps as Lung Cancer Treatment Gains Traction

Summit Therapeutics (NASDAQ:SMMT) is a Miami-based biopharmaceutical company that is focused on discovery, ...

SMMT : 8.68 (+4.70%)
Why Summit Therapeutics Stock Is Sinking Today

Investors continue to react negatively to recent late-stage results for Summit's experimental cancer therapy.

SMMT : 8.68 (+4.70%)
5 Top-Rated Russell 2000 Stocks Crushing the Market in 2024

With the Russell 2000 index taking a dip in 2024, these five top-rated RUT stocks are outshining their parent index and the broader market.

$SPX : 5,584.54 (-0.88%)
IWM : 210.68 (+3.59%)
GS : 479.23 (+0.07%)
AVO : 9.92 (+3.66%)
GEO : 15.57 (+3.04%)
LE : 15.73 (+8.26%)
PAYS : 4.14 (+5.61%)
SMMT : 8.68 (+4.70%)
Why Summit Therapeutics Stock Crushed the Market This Week

The company was a standout in the biotech field, rising by nearly 23% over the period.

SF : 84.35 (+1.26%)
SMMT : 8.68 (+4.70%)
Chart of the Day: Summit Therapeutics Begins to Soar

Caution: This company has had legal issues in the past. It is highly speculative. The Chart of the Day belongs to the oncology company Summit Therapeutics (SMMT) . I found the stock by using Barchart's...

SMMT : 8.68 (+4.70%)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Summit Therapeutics Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

SMMT : 8.68 (+4.70%)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Summit Therapeutics Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

SMMT : 8.68 (+4.70%)
Why Shares of Summit Therapeutics Slumped on Tuesday

The company's shares have been falling since it announced earnings late last week.

SMMT : 8.68 (+4.70%)
Why Shares of Summit Therapeutics Soared This Week

Summit Therapeutics advanced its lead therapy into two phase 3 trials to treat non-small cell lung cancer.

SMMT : 8.68 (+4.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Summit Therapeutics PLC is engaged in the discovery and development of drug to treat the fatal muscle wasting disease Duchenne Muscular Dystrophy and infections caused by the bacteria C. difficile. Summit Therapeutics PLC is headquartered in Abingdon, the United Kingdom.

See More

Key Turning Points

3rd Resistance Point 9.33
2nd Resistance Point 9.03
1st Resistance Point 8.85
Last Price 8.68
1st Support Level 8.37
2nd Support Level 8.07
3rd Support Level 7.89

See More

52-Week High 11.25
Last Price 8.68
Fibonacci 61.8% 7.53
Fibonacci 50% 6.39
Fibonacci 38.2% 5.24
52-Week Low 1.52

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar